Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$166,206,250
+$37,826,250 QoQ
Shares Held
3,275,000
0.0% QoQ
Ownership
4.47%
of shares outstanding
% of Portfolio
9.97%
of 13F equity value
Holder Rank
#6
of 210 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Commodore Capital LP holds $1,375,688,495 across 28 Biotechnology names. ELVN ranks #2 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLAY |
Relay Therapeutics, Inc.
|
12,000,000 | $224,520,000 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
This page
|
3,275,000 | $166,206,250 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,050,000 | $118,035,000 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
2,000,000 | $94,080,000 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
846,786 | $75,177,661 | |
| 6 | ANRO |
Alto Neuroscience, Inc.
|
2,723,196 | $71,865,142 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,250,000 | $70,335,000 | |
| 8 | EYPT |
EyePoint, Inc.
|
4,600,000 | $65,780,000 |
All Filings in ELVN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $166,206,250 | 3,275,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $128,380,000 | 3,275,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $188,196,848 | 4,800,940 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $72,269,258 | 4,692,809 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $96,061,800 | 4,692,809 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $94,137,748 | 4,692,809 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $92,004,000 | 4,675,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $94,612,500 | 4,205,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $104,714,000 | 4,100,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $92,854,735 | 3,973,245 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $69,889,379 | 3,973,245 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $40,161,133 | 2,901,816 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $39,638,806 | 2,901,816 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $47,928,231 | 2,348,272 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $37,916,893 | 1,731,365 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||